Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-03-05 @ 6:03 PM
Study NCT ID:
NCT00257205
Status:
COMPLETED
Last Update Posted:
2012-07-02
First Post:
2005-11-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melanoma | View |
Keywords: